Latest research findings on sexual medicine to be presented at 2000 Society for Study of Impotence Fall Research Meeting

Approximately 200 leading experts in sexual medicine will be in Cleveland at the Downtown Marriott Hotel September 15-17 to present and discuss the latest research findings related to diagnosing and treating sexual disorders. The presentations and discussion will be part of the 2000 Fall Research Meeting of the Society for the Study of Impotence.

During the meeting, about 60 researchers will present new peer-reviewed findings regarding sexual dysfunction, including new pharmaceutical treatments under development, diagnosing and treating female sexual dysfunction, and the relationship between prostate cancer treatments and developing erectile dysfunction. In addition to these new research findings, the meeting also features internationally renowned clinicians and researchers who have been invited to make special Grand Master Lecture presentations on several key topics in sexual medicine, including erectile dysfunction after treatment for prostate cancer, the psychogenic causes of sexual disorders, and oral therapy for female sexual dysfunction.

"The information to be presented at this scientific forum represents the state-of-the-art in preventing, diagnosing, treating, and managing disorders impacting on sexual function," says Dr. Robert P. Nelson, a urologist at the Medical University of South Carolina and president of the Society for the Study of Impotence. "The knowledge in this medical discipline is increasing so rapidly that it is difficult for medical professionals and the general public to stay informed. It's meetings like this that help everyone stay up-to-date."

Some of the new findings that will be presented and discussed during the meeting include:

• Data on the sexual function of men after a radical prostatectomy to treat prostate cancer.

• The effect of hysterectomy on female sexual function and recommendations on how this procedure might be improved to decrease impact on sexual function.

• Improved arousal in women with sexual dysfunction using a clitoral vacuum device.

• Benefits of IC 351--a highly selective inhibitor of PDE5-- in men with erectile dysfunction

• Data on the safety of apomorphine SL in patients who also are taking hypertensive medications.

• The role of a new topical testosterone gel for male hormonal supplementation in improving sexual desire and erections.

• The relationship of sleep disorders and erectile dysfunction.

• Vascular endothelial growth factor (VEGF) as a possible treatment option for erectile dysfunction related to venous leak.

• Endothelial dysfunction as a cause of erectile dysfunction is independent of the ageing process when associated with hypercholestremia.

• The ability of vardenafil--a new PDE5 inhibitor--to enhance erections.

In addition to these and many other original research presentations, several plenary presentations also will examine some of the key issues related to sexual medicine, including:

• A series of Grand Master Lectures discussing the relationship of erectile dysfunction and treatment for prostate cancer. (Saturday, September 16 beginning at 8:20 a.m.)

• Grand Master Lectures on male and female psychologic sexuality issues. (Saturday, September 16 beginning at 10:45 a.m.)

• Information on sexual function and HIV. (Sunday, September 17 beginning at 8:10 a.m.) (more)

• Oral therapy for female sexual dysfunction. (Sunday, September 17 beginning at 9 a.m.)

• Sexual function after spinal cord injury. (Sunday, September 17 beginning at 8:35 a.m.)

• The relationship of hypertension and erectile dysfunction. (Sunday, September 17 beginning at 9:30 a.m.)